John B. Landis

Insider Reports History

Location
West Lafayette, IN
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Landis:

Company Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 21,400 $185,752 $8.68 05 Jan 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Restricted Stock Units 0 $0 $8.68 05 Jan 2025 Direct
EyePoint, Inc. Director Stock Option (Right to Buy) 40,000 02 Jan 2026 Direct

Insider Reports Filed by John B. Landis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYPT EyePoint, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:06
EYPT EyePoint Pharmaceuticals, Inc. 03 Jan 2025 3 $0 4 Director 07 Jan 2025, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 3 $0 4 Director 09 Jan 2024, 20:55
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 09:21
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2023 2 $0 4 Director 13 Feb 2023, 16:05
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2022 4 $0 4 Director 11 Feb 2022, 15:54
EYPT EyePoint Pharmaceuticals, Inc. 22 Jun 2021 2 $0 4 Director 23 Jun 2021, 17:30